Cargando...
Population pharmacokinetics of single-dose riociguat in patients with renal or hepatic impairment
Abstract. This population pharmacokinetics (PK) analysis characterized the PK of the oral soluble guanylate cyclase stimulator riociguat in patients with renal or hepatic impairment and determined whether smoking affects riociguat dosing. Two phase 1 studies were performed in patients with renal imp...
Guardado en:
| Publicado en: | Pulm Circ |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
University of Chicago Press
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4860534/ https://ncbi.nlm.nih.gov/pubmed/27162631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/685647 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|